A meta-analysis was conducted to evaluate possible neuropsychological
effects of treatments for cancer in adults. A search revealed 30
studies, encompassing 29 eligible samples, and leading to inclusion of
a total of 838 patients and control participants. A total of 173 effect
sizes (Cohen's d) were extracted across 7 cognitive
domains and as assessed in the literature via 3 methods of comparison
(post-treatment compared with normative data, controls, or baseline
performance). Statistically significant negative effect sizes were
found consistently across both normative and control methods of
comparison for executive function, verbal memory, and motor function.
The largest effects were for executive function and verbal memory
normative comparisons (−.93 and −.91, respectively). When
limiting the sample of studies in the analyses to only those with
relatively “less severe” diagnoses and treatments, the
effects remained. While these results point toward some specific
cognitive effects of systemic cancer therapies in general, no clear
clinical implications can yet be drawn from these results. More
research is needed to clarify which treatments may produce cognitive
decrements, the size of those effects, and their duration, while ruling
out a wide variety of possible mediating or moderating variables.
(JINS, 2003, 9, 967–982.)